Loading...
•
Mar 31
Zoetis Q1 2025 Earnings Report
Zoetis reported modest revenue growth and solid earnings performance in Q1 2025.
Key Takeaways
Zoetis delivered $2.2 billion in revenue and $631 million in net income, with strong performance in companion animal products driving 9% organic growth.
Revenue reached $2.2 billion, with 9% organic growth driven by companion animal products.
Net income was $631 million, up 5% from the previous year.
Adjusted EPS came in at $1.48, compared to $1.38 in Q1 2024.
Livestock segment declined due to divestitures, partially offset by strength in emerging markets.
Zoetis
Zoetis
Zoetis Revenue by Segment
Zoetis Revenue by Geographic Location
Revenue by Segment
Companion Animal Revenue
CapyFin.comLivestock Revenue
CapyFin.comContract Mfg. & Human Health Revenue
CapyFin.comRevenue by Geographic Location
U.S. Revenue
CapyFin.comInternational Revenue
CapyFin.com Forward Guidance
Zoetis updated its full-year 2025 guidance reflecting foreign exchange and tariff impacts while maintaining strong operational growth expectations.
Positive Outlook
- Revenue guidance raised to $9.425B–$9.575B
- Maintained 6%–8% organic revenue growth guidance
- Adjusted EPS raised to $6.20–$6.30
- Adjusted net income expected between $2.775B–$2.825B
- Strong product approvals across companion and livestock portfolios
Challenges Ahead
- Foreign exchange headwinds impacted reported growth
- Livestock segment affected by divestiture of MFA portfolio
- Tariffs pressured profit margins
- Softness in poultry and swine segments
- Decreased R&D investment margin due to increased SG&A spending
Revenue & Expenses
Visualization of income flow from segment revenue to net income